Showing results (561-570 of 584) with videos related to

Sort By:
Pageof 59
Nature Medicine|March 4, 2020
Diagnostic value of plasma phosphorylated tau181 in Alzheimer's disease and frontotemporal lobar degenerationElisabeth H Thijssen, Renaud La Joie, Amy Wolf, et al.
Neurology|May 18, 2022
Sensitivity of the Social Behavior Observer Checklist to Early Symptoms of Patients With Frontotemporal DementiaGianina Toller, Yann Cobigo, Peter A Ljubenkov, et al.
Neurology|July 3, 2024
CSF Proteomics in Patients With Progressive Supranuclear PalsyAmy Wise, Jingyao Li, Mai Yamakawa, et al.
Journal of the International Neuropsychological Society : JINS|October 30, 2025
Development and validation of the TabCAT-EXAMINER: A tablet-based executive functioning battery for research and clinical trialsMark Sanderson-Cimino, Katherine L Possin, Dan M Mungas, et al.
JAMA Neurology|June 22, 2026
Clinical Associations of Cerebrospinal Fluid TMEM106B in Familial and Sporadic Frontotemporal DementiaMolly Olzinski, Joshua Downer, Yann Cobigo, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|January 2, 2023
Multisite ALLFTD study modeling progressive empathy loss from the earliest stages of behavioral variant frontotemporal dementiaGianina Toller, Yann Cobigo, Patrick Callahan, et al.
Nature|September 30, 2017
ApoE4 markedly exacerbates tau-mediated neurodegeneration in a mouse model of tauopathyYang Shi, Kaoru Yamada, Shane Antony Liddelow, et al.
The Lancet. Neurology|August 21, 2021
Plasma phosphorylated tau 217 and phosphorylated tau 181 as biomarkers in Alzheimer's disease and frontotemporal lobar degeneration: a retrospective diagnostic performance studyElisabeth H Thijssen, Renaud La Joie, Amelia Strom, et al.
Cell Reports. Medicine|May 2, 2022
Comprehensive cross-sectional and longitudinal analyses of plasma neurofilament light across FTD spectrum disordersTania F Gendron, Michael G Heckman, Launia J White, et al.
The Journal of Prevention of Alzheimer'S Disease|January 25, 2026
Potential role of MRI to optimize clinical trial design for progressive supranuclear palsy and corticobasal degenerationJesús García-Castro, Lawren VandeVrede, Michael C Donohue, et al.
Pageof 59